Neohesperidin Dihydrochalcone Reduces Vascular Dysfunction Caused by Lipopolysaccharide
Author Information
Author(s): Nong Yuxin, Lu Junquan, Yu Danqing, Wei Xuebiao
Primary Institution: Guangdong Provincial People's Hospital
Hypothesis
Does neohesperidin dihydrochalcone (NHDC) alleviate lipopolysaccharide (LPS)-induced vascular dysfunction?
Conclusion
Pretreatment with NHDC may protect against LPS-induced vascular dysfunction by reducing oxidative stress and inflammatory signaling.
Supporting Evidence
- NHDC reduced protein extravasation in response to LPS intervention.
- NHDC improved survival rates in mice after LPS injection.
- NHDC decreased the levels of inflammatory cytokines IL-1β, IL-6, and TNF-α.
- NHDC enhanced antioxidant capacity by increasing CAT, SOD, and GSH levels.
- NHDC mitigated LPS-induced apoptosis in endothelial cells.
Takeaway
This study shows that a sweetener called NHDC can help protect blood vessels from damage caused by bacteria.
Methodology
The study used in vivo and in vitro experiments to assess the effects of NHDC on vascular leakage and endothelial cell function.
Limitations
The study used a mouse model which may not fully replicate human sepsis conditions.
Participant Demographics
C57BL/6 male mice, 8 weeks old, weighing 20–25 g.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website